Loading…
Parnax Lab (PARNAXLAB)₹108.45+1.36%Pharmaceuticals
Parnax Lab is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 14.0 against a peer median of 20.2, and ROCE of 14.1% against a peer median of 11.1%, and latest-quarter sales growth of 6.4% against a peer median of 25.3%. By market cap it is #9 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Drugs and Chemicals | 139 | 9.6 | 17.0 | 12.4 | 0.00 | 0.0 | 104 | 13 | 20.2 | 41.6 | vs PARNAXLAB |
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | vs PARNAXLAB |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs PARNAXLAB |
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | vs PARNAXLAB |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | vs PARNAXLAB |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs PARNAXLAB |
| Asston Pharmaceuticals | 129 | 33.3 | 16.8 | 15.5 | 0.13 | 0.0 | 25 | 4 | 10.8 | −75.8 | vs PARNAXLAB |
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | vs PARNAXLAB |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | — |
| Godavari Drugs | 122 | 24.2 | 7.0 | 6.4 | 1.00 | 0.0 | 106 | 4 | 30.1 | 45.5 | vs PARNAXLAB |
| Alpa Laboratories | 119 | 28.6 | 9.1 | 8.3 | 0.02 | 0.0 | 106 | 15 | 25.3 | −91.6 | vs PARNAXLAB |
| Peer median | 129 | 20.2 | 11.1 | 11.1 | 0.55 | 0.0 | 106 | 6 | 25.3 | 43.5 |
Listed companies closest to Parnax Lab in Pharmaceuticals include Par Drugs and Chemicals, Speciality Medicines, Parnax Lab, Bal Pharma, Lactose (India), Krebs Biochemicals and Industries, Asston Pharmaceuticals, BALAXI PHARMACEUTICALS.
Par Drugs and Chemicals, with a market cap of ₹139 Cr.
Parnax Lab trades at a P/E of 14.0; the median of its peer set is 20.2. A P/E above or below the median is a description, not a judgement on value.
Parnax Lab's return on capital employed is 14.1%, above the peer median of 11.1%.